Cargando…

WHO criteria for diabetes in pregnancy: a retrospective cohort

BACKGROUND: Recognizing that hyperglycemia in pregnancy can impact both individually a patient’s health and collectively the healthcare system and that different levels of hyperglycemia incur different consequences, we aimed to evaluate the differences and similarities between patients who met the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaccara, Tatiana A., Paganoti, Cristiane F., Mikami, Fernanda C. F., Francisco, Rossana P. V., Costa, Rafaela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066879/
https://www.ncbi.nlm.nih.gov/pubmed/35505301
http://dx.doi.org/10.1186/s12884-022-04708-w
_version_ 1784699888440705024
author Zaccara, Tatiana A.
Paganoti, Cristiane F.
Mikami, Fernanda C. F.
Francisco, Rossana P. V.
Costa, Rafaela A.
author_facet Zaccara, Tatiana A.
Paganoti, Cristiane F.
Mikami, Fernanda C. F.
Francisco, Rossana P. V.
Costa, Rafaela A.
author_sort Zaccara, Tatiana A.
collection PubMed
description BACKGROUND: Recognizing that hyperglycemia in pregnancy can impact both individually a patient’s health and collectively the healthcare system and that different levels of hyperglycemia incur different consequences, we aimed to evaluate the differences and similarities between patients who met the diagnostic criteria for gestational diabetes mellitus (GDM) or diabetes in pregnancy (DIP) according to the World Health Organization diagnostic criteria based on the 75 g oral glucose tolerance test (OGTT). METHODS: This retrospective study included a cohort of 1064 women followed-up at the Gestational Diabetes Unit of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (Sao Paulo, Brazil). Patients were classified into GDM and DIP groups, according to their OGTT results. Their electronic charts were reviewed to obtain clinical and laboratory data for all participants. RESULTS: Women in the DIP group had a higher pre-pregnancy body mass index (30.5 vs 28.1 kg/m(2), odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02–1.11), more frequently experienced GDM in a previous pregnancy (25% vs. 11%, OR 2.71, 95% CI 1.17–6.27), and were more likely to have chronic hypertension (43.1% vs. 23.5%, OR 2.46, 95% CI 1.47–4.11), a current twin pregnancy (10.8% vs. 2.9%, OR 4.04, 95% CI 1.70–9.61), or require insulin (46.1% vs. 14.3%, OR 5.14, 95% CI 3.06–8.65) than those in the GDM group. Patients in the DIP group also had a higher frequency of large-for-gestational-age infants (12.3% vs. 5.1%, OR 2.78, 95% CI 1.23–6.27) and abnormal postpartum OGTT (45.9% vs. 12.6%, OR 5.91, 95% CI 2.93–11.90) than those in the GDM group. Nevertheless, in more than half of the DIP patients, glucose levels returned to normal after birth. CONCLUSIONS: Diabetes in pregnancy is associated with an increased risk of adverse perinatal outcomes but does not equate to a diagnosis of diabetes post-pregnancy. It is necessary to identify and monitor these women more closely during and after pregnancy. Keeping patients with hyperglycemia in pregnancy engaged in healthcare is essential for accurate diagnosis and prevention of complications related to abnormal glucose metabolism.
format Online
Article
Text
id pubmed-9066879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90668792022-05-04 WHO criteria for diabetes in pregnancy: a retrospective cohort Zaccara, Tatiana A. Paganoti, Cristiane F. Mikami, Fernanda C. F. Francisco, Rossana P. V. Costa, Rafaela A. BMC Pregnancy Childbirth Research BACKGROUND: Recognizing that hyperglycemia in pregnancy can impact both individually a patient’s health and collectively the healthcare system and that different levels of hyperglycemia incur different consequences, we aimed to evaluate the differences and similarities between patients who met the diagnostic criteria for gestational diabetes mellitus (GDM) or diabetes in pregnancy (DIP) according to the World Health Organization diagnostic criteria based on the 75 g oral glucose tolerance test (OGTT). METHODS: This retrospective study included a cohort of 1064 women followed-up at the Gestational Diabetes Unit of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (Sao Paulo, Brazil). Patients were classified into GDM and DIP groups, according to their OGTT results. Their electronic charts were reviewed to obtain clinical and laboratory data for all participants. RESULTS: Women in the DIP group had a higher pre-pregnancy body mass index (30.5 vs 28.1 kg/m(2), odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02–1.11), more frequently experienced GDM in a previous pregnancy (25% vs. 11%, OR 2.71, 95% CI 1.17–6.27), and were more likely to have chronic hypertension (43.1% vs. 23.5%, OR 2.46, 95% CI 1.47–4.11), a current twin pregnancy (10.8% vs. 2.9%, OR 4.04, 95% CI 1.70–9.61), or require insulin (46.1% vs. 14.3%, OR 5.14, 95% CI 3.06–8.65) than those in the GDM group. Patients in the DIP group also had a higher frequency of large-for-gestational-age infants (12.3% vs. 5.1%, OR 2.78, 95% CI 1.23–6.27) and abnormal postpartum OGTT (45.9% vs. 12.6%, OR 5.91, 95% CI 2.93–11.90) than those in the GDM group. Nevertheless, in more than half of the DIP patients, glucose levels returned to normal after birth. CONCLUSIONS: Diabetes in pregnancy is associated with an increased risk of adverse perinatal outcomes but does not equate to a diagnosis of diabetes post-pregnancy. It is necessary to identify and monitor these women more closely during and after pregnancy. Keeping patients with hyperglycemia in pregnancy engaged in healthcare is essential for accurate diagnosis and prevention of complications related to abnormal glucose metabolism. BioMed Central 2022-05-03 /pmc/articles/PMC9066879/ /pubmed/35505301 http://dx.doi.org/10.1186/s12884-022-04708-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zaccara, Tatiana A.
Paganoti, Cristiane F.
Mikami, Fernanda C. F.
Francisco, Rossana P. V.
Costa, Rafaela A.
WHO criteria for diabetes in pregnancy: a retrospective cohort
title WHO criteria for diabetes in pregnancy: a retrospective cohort
title_full WHO criteria for diabetes in pregnancy: a retrospective cohort
title_fullStr WHO criteria for diabetes in pregnancy: a retrospective cohort
title_full_unstemmed WHO criteria for diabetes in pregnancy: a retrospective cohort
title_short WHO criteria for diabetes in pregnancy: a retrospective cohort
title_sort who criteria for diabetes in pregnancy: a retrospective cohort
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066879/
https://www.ncbi.nlm.nih.gov/pubmed/35505301
http://dx.doi.org/10.1186/s12884-022-04708-w
work_keys_str_mv AT zaccaratatianaa whocriteriafordiabetesinpregnancyaretrospectivecohort
AT paganoticristianef whocriteriafordiabetesinpregnancyaretrospectivecohort
AT mikamifernandacf whocriteriafordiabetesinpregnancyaretrospectivecohort
AT franciscorossanapv whocriteriafordiabetesinpregnancyaretrospectivecohort
AT costarafaelaa whocriteriafordiabetesinpregnancyaretrospectivecohort